PHM7D Stock Overview
Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 2/6 |
Dividends | 6/6 |
Altria Group, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$40.05 |
52 Week High | US$41.65 |
52 Week Low | US$36.17 |
Beta | 0.70 |
1 Month Change | -0.85% |
3 Month Change | 7.59% |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -7.45% |
Recent News & Updates
Recent updates
Shareholder Returns
PHM7D | GB Tobacco | GB Market | |
---|---|---|---|
7D | 3.6% | 1.0% | 2.8% |
1Y | n/a | -17.6% | 1.1% |
Return vs Industry: Insufficient data to determine how PHM7D performed against the UK Tobacco industry.
Return vs Market: Insufficient data to determine how PHM7D performed against the UK Market.
Price Volatility
PHM7D volatility | |
---|---|
PHM7D Average Weekly Movement | n/a |
Tobacco Industry Average Movement | 2.8% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.3% |
10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: PHM7D has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PHM7D's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1822 | 6,400 | Billy Gifford | www.altria.com |
Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and snus products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand.
Altria Group, Inc. Fundamentals Summary
PHM7D fundamental statistics | |
---|---|
Market cap | €69.65b |
Earnings (TTM) | €7.90b |
Revenue (TTM) | €19.12b |
8.8x
P/E Ratio3.6x
P/S RatioIs PHM7D overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PHM7D income statement (TTM) | |
---|---|
Revenue | US$20.46b |
Cost of Revenue | US$6.25b |
Gross Profit | US$14.21b |
Other Expenses | US$5.75b |
Earnings | US$8.45b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 31, 2024
Earnings per share (EPS) | 4.92 |
Gross Margin | 69.45% |
Net Profit Margin | 41.32% |
Debt/Equity Ratio | -494.5% |
How did PHM7D perform over the long term?
See historical performance and comparison